Keyphrases
Pediatric Acute Lymphoblastic Leukemia
100%
3D Chromatin Organization
100%
NSD2
100%
Gene Expression
42%
Drug Resistance
42%
RNA Sequencing (RNA-seq)
28%
H3K36me3
28%
Therapeutic Intervention
14%
H3K27me3
14%
Systematic Integration
14%
Acute Lymphoblastic Leukemia
14%
Leukemia Patients
14%
Relapsed or Refractory Acute Myeloid Leukemia
14%
Chromatin Immunoprecipitation (ChIP)
14%
Transcriptional Program
14%
Clonal Evolution
14%
Gene Pathway
14%
Chromatin Accessibility
14%
Phenotypic Differences
14%
Leukemia Cell Lines
14%
Topologically Associating Domains
14%
Evolution Resistance
14%
B-cell Acute Lymphoblastic Leukemia (B-ALL)
14%
3D Chromatin Structure
14%
Chromatin Compaction
14%
ATAC-seq
14%
Acute Lymphoblastic Leukemia Cells
14%
Cell Context
14%
High-throughput Chromosome Conformation Capture (Hi-C)
14%
Core Program
14%
3D Genome
14%
Hi-C Data
14%
Common Core
14%
Decompaction
14%
Shared Driving
14%
Biochemistry, Genetics and Molecular Biology
Drug Resistance
100%
Drive
100%
Gene Expression
66%
RNA Sequence
33%
RNA Sequencing
33%
Clonal Evolution
33%
ATAC-Seq
33%
Chromatin Accessibility
33%
Immunology and Microbiology
Drug Resistance
100%
Gene Expression
66%
Cell Line
66%
RNA Sequence
33%
RNA Sequencing
33%
Clonal Evolution
33%
Leukemia Cell Line
33%